News

Novartis announced that the European Commission (EC) approved Tabrecta (capmatinib) as a monotherapy for the treatment of adults with advanced non-small cell lung cancer (NSCLC)…
Read More...

Radius Health, Inc. announced that it has entered into a definitive agreement to be acquired by Gurnet Point Capital and Patient Square Capital in a transaction valued at approximately…
Read More...

Novavax, Inc. announced that the Taiwan Food and Drug Administration has granted emergency use authorization (EUA) for Nuvaxovid (NVX-CoV2373) COVID-19 vaccine in individuals aged 18…
Read More...

Ellipses Pharma (“Ellipses”), a global drug development company focused on accelerating the development of cancer medicines and treatments through an innovative drug development model,…
Read More...

Johnson & Johnson (the Company) announced the launch of the new J&J Satellite Center for Global Health Discovery (Satellite Center) at Singapore’s Duke-NUS Medical School,…
Read More...

Echosens, a high-technology company offering liver diagnostic solutions, and Novo Nordisk A/S, a leading global healthcare company, announced a partnership to advance early diagnosis of…
Read More...

VBI Vaccines Inc. (VBI), a biopharmaceutical company driven by immunology in the pursuit of powerful prevention and treatment of disease, announced that the U.S. Food and Drug…
Read More...

Galapagos NV, CellPoint and AboundBio announced that both companies have entered into definitive agreements with Galapagos, propelling Galapagos into next-generation cell therapy while …
Read More...

ANI Pharmaceuticals, Inc. (ANI or the Company) announced that the Company received U.S. Food and Drug Administration (FDA) approval for the Abbreviated New Drug Application (ANDA) for…
Read More...

Merck announced that the U.S. Food and Drug Administration (FDA) has approved an expanded indication for VAXNEUVANCE (Pneumococcal 15-valent Conjugate Vaccine) (pronounced…
Read More...

Truveta announced a strategic collaboration with Pfizer to deliver new safety insights on a continuous basis, using verifiable real-world data at scale. Truveta will provide Pfizer with…
Read More...

One year since the establishment of the mRNA Vaccine Technology Transfer Hub, a collaboration between two of the world’s leading biotech companies - Afrigen Biologics and the…
Read More...

BioMarin Pharmaceutical Inc. announced that the Ministry of Health, Labor and Welfare (MHLW) in Japan granted approval of the registration of VOXZOGO (vosoritide) for injection,…
Read More...

Moderna, Inc . announced an agreement in principle with the United Kingdom government to establish an mRNA Innovation and Technology Center in the UK. This state-of-the-art mRNA vaccine…
Read More...

Kinarus Therapeutics Holding AG, a clinical-stage biopharmaceutical company developing novel therapeutics to treat viral, respiratory, and ophthalmic diseases, announced publication in…
Read More...

Waters Corporation announced a collaboration with BioInfra, a pioneering contract research organization (CRO) company for the pharmaceutical and clinical fields, to jointly establish…
Read More...

Sandoz, a global leader in generic and biosimilar medicines, announced that the European Medicines Agency (EMA) has accepted the application for high concentration formulation 100 mg/mL…
Read More...

Hansa Biopharma, "Hansa" announces the recommendation by the National Institute for Health and Care Excellence (NICE) for its first-in-class treatment Idefirix in the desensitization of…
Read More...

Exelixis, Inc. and BioInvent International AB announced that the companies have entered into an option and license agreement focused on the identification and development of novel…
Read More...

Panbela Therapeutics, Inc. a clinical stage company developing disruptive therapeutics for the treatment of patients with cancer, announced the closing of its acquisition of Cancer…
Read More...